A DYNAMIC OLIGOPOLY STRUCTURAL MODEL FOR THE PRESCRIPTION DRUG MARKET AFTER PATENT EXPIRATION*

Andrew T. Ching

149 citations0/0 files storedInternational Economic Review

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Merger and Competition Analysis Consumer Market Behavior and Pricing

Abstract

This article incorporates consumer learning and heterogeneity into a dynamic oligopoly model for the prescription drug market. In the model, both firms and patients need to learn the generic qualities via patients' experiences, generic firms' entry decisions are endogenous, but their entry timings depend on a random approval process. I apply the model to examine the impact of shortening the expected generic approval time. Although this policy experiment brings generics to the market sooner, it increases a potential entrant's likelihood of entering a crowded market and hence could reduce the total number of generic entrants and consumer welfare.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 149 citations exist upstream.

References

1995Automobile Prices in Market Equilibrium 1984A Method for Minimizing the Impact of Distributional Assumptions in Econometric Models for Duration Data 1995Markov-Perfect Industry Dynamics: A Framework for Empirical Work 1992Discrete Choice Theory of Product Differentiation 1989A Method of Simulated Moments for Estimation of Discrete Response Models Without Numerical Integration 1989Simulation and the Asymptotics of Optimization Estimators 1996Decision-Making Under Uncertainty: Capturing Dynamic Brand Choice Processes in Turbulent Consumer Goods Markets 1984Patents as Options: Some Estimates of the Value of Holding European Patent Stocks

Cited by

2012Physician Agency and Adoption of Generic Pharmaceuticals 2012Pharmaceutical Prices under Regulation: Tiered Co-payments and Reference Pricing in Germany 2007Chapter 30 A Framework for Applied Dynamic Analysis in IO 2014The Economics of Predation: What Drives Pricing When There Is Learning-by-Doing?2013Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.